Veracyte, Inc. (VCYT) is listed on NASDAQ in Healthcare Services Stocks. It is $43.36, -4.19%, with a $3.5B market cap. RSI is 38.8, near oversold. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 38.8 Near Oversold
Market Cap $3.5B
Volume 1.0M
Fundamentals — 10-Q Q2 2026
Revenue $289.4M
Net Income $54.2M
EPS $0.66
Gross Margin 72.5%
Operating Margin 15.8%
Net Margin 18.7%
P/E Ratio 65.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Eastham Karin | Director | Sell | 3,729 | $52.89 | $197,234 | 2026 Jun 18 |
| McGuire Annie | EVP, General Counsel | Sell | 3,176 | $49.76 | $158,036 | 2026 Jun 4 |
| Chambers Rebecca | Chief Financial Officer | Sell | 3,561 | $49.73 | $177,083 | 2026 Jun 4 |
| Stapley Marc | Chief Executive Officer | Sell | 138,051 | $50.12 | $6.9M | 2026 Jun 4 |
| Leite John | Global Chief Commercial Off | Sell | 13,975 | $50.07 | $699,732 | 2026 Jun 4 |
| Wygant Jonathan | VP, Chief Accounting Officer | Sell | 24,000 | $45.40 | $1.1M | 2026 May 22 |
| Epstein Robert S | Director | Sell | 10,000 | $44.01 | $440,129 | 2026 May 20 |
| McGuire Annie | SVP, General Counsel | Sell | 10,204 | $39.02 | $398,211 | 2026 May 6 |
| Chambers Rebecca | Chief Financial Officer | Sell | 18,341 | $36.14 | $662,869 | 2026 Mar 4 |
| Stapley Marc | Chief Executive Officer | Sell | 45,523 | $35.97 | $1.6M | 2026 Mar 4 |
| Leite John | Chief Commercial Officer-CLIA | Sell | 5,260 | $35.19 | $185,083 | 2026 Mar 4 |
| McGuire Annie | SVP, General Counsel | Sell | 6,658 | $35.55 | $236,725 | 2026 Mar 4 |
| Febbo Phillip G. | Chief Scientific & Med Officer | Sell | 13,425 | $36.16 | $485,429 | 2026 Mar 2 |
| McGuire Annie | SVP, General Counsel | Sell | 10,739 | $43.14 | $463,228 | 2025 Dec 16 |
| Eastham Karin | Director | Sell | 20,000 | $45.45 | $908,963 | 2025 Dec 5 |
| McGuire Annie | SVP, General Counsel | Sell | 1,422 | $47.30 | $67,264 | 2025 Dec 4 |
| Chambers Rebecca | Chief Financial Officer | Sell | 13,278 | $46.84 | $621,922 | 2025 Dec 4 |
| Stapley Marc | Chief Executive Officer | Sell | 7,668 | $47.09 | $361,078 | 2025 Dec 4 |
| Leite John | Chief Commercial Officer-CLIA | Sell | 1,278 | $47.51 | $60,718 | 2025 Dec 4 |
| Jones Evan/ Fa | Director | Sell | 1,106 | $50.25 | $55,577 | 2025 Nov 25 |
Other Healthcare Services Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $894.35 | 58.3 | $104.3B |
| | $417.60 | 60.5 | $92.6B |
| | $321.94 | 56.1 | $61.4B |
| | $49.73 | 63.2 | $2.6B |
Take VCYT further
- Browse Healthcare Services Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put VCYT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Veracyte, Inc. next reports.
Set alerts on VCYT
Get notified when Veracyte, Inc. hits your price targets or technical conditions are met.
Get Started Free